4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-024118
Chairman and CEO bought 9,900 shares at an average $1.29 ($12,736)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-04-08 | Purchase | +3,200 | $1.30 | $4,160 | 10,578,243 | D |
| Niihara Yutaka Chairman and CEO | 2020-04-09 | Purchase | +6,700 | $1.28 | $8,576 | 10,584,943 | D |
| Open-market purchases · 9,900 sh · avg $1.29 · $12,736 | |||||||
Loading xslF345X03/doc4.xml…